文献速递儿童青少年精神精神分裂症与精神病性障碍心境障碍

医疗系统人群中神经发育精神疾病基因罕见致病变异的患病率与外显率

Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population.
PubMed 文献 · Am J Psychiatry · 2022-12-07

该研究基于Geisinger医疗系统DiscovEHR队列中90,595名参与者,分析94个高置信度神经发育精神疾病(NPD)基因的功能丧失致病变异,发现0.34%携带致病变异且NPD外显率为34.3%,单基因变异与拷贝数变异(CNV)类似,共同增加孤独症、精神分裂症和双相障碍等风险。

要点

  • 0.34%的医疗系统人群携带NPD基因致病变异,NPD外显率为34.3%。
  • 单基因变异与CNV类似,共同增加孤独症、精神分裂症和双相障碍风险。
  • 排除智力障碍者后NPD风险仍显著,提示对无严重认知缺陷者同样适用。

核心结论

  • 罕见单基因致病变异和CNV在医疗系统人群中合计超过1%,对精神健康障碍有重要贡献作用。
  • 对出现症状的NPD个体进行致病基因诊断检测,可能通过早期干预和预见性治疗支持改善临床结局。

研究设计与样本

  • 研究分析Geisinger MyCode社区健康倡议中DiscovEHR队列的90,595名参与者的关联基因组与电子健康记录数据。
  • 通过外显子测序识别94个高置信度NPD基因中的功能丧失致病变异,使用预设电子健康记录诊断代码计算NPD外显率。
  • 通过有无NPD诊断的DiscovEHR参与者进行病例对照比较估计NPD风险,并将单基因变异分析结果与31个既往报道的致病性NPD CNV结果比较。

主要发现

  • DiscovEHR队列中0.34%的参与者携带致病性变异,这些变异对NPD的外显率为34.3%。
  • 与CNV类似,序列变异集体赋予孤独症、精神分裂症和双相障碍等多种NPD诊断的显著风险。
  • 排除智力障碍参与者后,NPD风险仍显著,确认了与无严重认知缺陷个体中主要精神障碍的关联。

关键数值与推荐

  • 94个高置信度NPD基因中功能丧失致病变异的患病率为0.34%。
  • 致病性变异对NPD的外显率为34.3%。
  • 罕见单基因变异和CNV在医疗系统人群中合计超过1%。

临床怎么用

  • 对出现症状的NPD个体可考虑致病基因诊断检测,以通过早期干预和预见性治疗支持改善临床结局。
  • 在无严重认知缺陷的个体中,仍应关注单基因致病变异相关的主要精神障碍风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Autism, schizophrenia, and other clinically distinct neurodevelopmental psychiatric disorders (NPDs) have shared genetic etiologies, including single-gene and multigenic copy number variants (CNVs). Because rare variants are primarily investigated in clinical cohorts, population-based estimates of their prevalence and penetrance are lacking. The authors determined the prevalence, penetrance, and NPD risk of pathogenic single-gene variants in a large health care system population. METHODS: The authors analyzed linked genomic and electronic health record (EHR) data in a subset of 90,595 participants from Geisinger's MyCode Community Health Initiative, known as the DiscovEHR cohort. Loss-of-function pathogenic variants in 94 high-confidence NPD genes were identified through exome sequencing, and NPD penetrance was calculated using preselected EHR diagnosis codes. NPD risk was estimated using a case-control comparison of DiscovEHR participants with and without NPD diagnoses. Results from single-gene variant analyses were also compared with those from 31 previously reported pathogenic NPD CNVs. RESULTS: Pathogenic variants were identified in 0.34% of the DiscovEHR cohort and demonstrated a 34.3% penetrance for NPDs. Similar to CNVs, sequence variants collectively conferred a substantial risk for several NPD diagnoses, including autism, schizophrenia, and bipolar disorder. Significant NPD risk remained after participants with intellectual disability were excluded from the analysis, confirming the association with major psychiatric disorders in individuals without severe cognitive deficits. CONCLUSIONS: Collectively, rare single-gene variants and CNVs were found in >1% of individuals in a large health care system population and play an important contributory role in mental health disorders. Diagnostic genetic testing for pathogenic variants among symptomatic individuals with NPDs could improve clinical outcomes through early intervention and anticipatory therapeutic support.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Shimelis H, Oetjens MT, Walsh LK, et al. Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population. Am J Psychiatry. 2022. PMID: 36475376. doi:10.1176/appi.ajp.22010062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。